文献速递冠心病血脂与心血管预防

冠状动脉血流速度储备可预测无梗阻性冠心病心绞痛女性的不良预后:iPOWER研究

Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study.
PubMed 文献 · Eur Heart J · 2021-01-01

iPOWER前瞻性研究纳入1853例造影无梗阻性冠心病的心绞痛女性,采用多普勒超声评估左前降支冠状动脉血流速度储备(CFVR)。中位随访4.5年,CFVR每降低0.1单位与复合终点风险独立相关(多因素HR 1.05,95%CI 1.01-1.09,P=0.01),主要驱动心肌梗死和心力衰竭风险增加,支持对这类患者更积极的预防管理。

要点

  • 无梗阻性冠心病心绞痛女性中,超声评估CFVR可行(91%患者获得)。
  • CFVR每降低0.1单位,复合心血管事件风险独立增加5%。
  • CFVR降低主要与心肌梗死和心力衰竭风险增加相关。

核心结论

  • 超声评估CFVR可行,并能预测无梗阻性冠心病心绞痛女性的不良结局。
  • 结果支持对这类患者进行更积极的预防管理,并强调需要针对冠状动脉微血管功能障碍的试验。

研究设计与样本

  • 前瞻性iPOWER研究,筛查7253例后纳入1853例造影无梗阻性冠心病的心绞痛女性,排除既往冠心病、心力衰竭或瓣膜病患者。
  • 采用多普勒超声评估左前降支CFVR,随访复合终点包括心血管死亡、心肌梗死、心力衰竭、卒中和冠状动脉血运重建。

主要发现

  • 1681例(91%)获得CFVR,中位CFVR为2.33(四分位1-3:2.00-2.74)。
  • 中位随访4.5年发生96例事件。
  • 单因素Cox回归中,CFVR每降低0.1单位与复合终点相关(HR 1.07,95%CI 1.03-1.11,P<0.001),主要由心肌梗死和心力衰竭风险增加驱动。
  • 多因素分析中结果仍显著(HR 1.05,95%CI 1.01-1.09,P=0.01)。
  • 探索性分析中,CFVR还与因心绞痛反复住院和全因死亡风险相关。

临床怎么用

  • 对无梗阻性冠心病的心绞痛女性,可考虑采用超声多普勒评估CFVR以识别冠状动脉微血管功能障碍。
  • CFVR降低提示不良预后风险增加,应加强预防性管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Many patients with angina, especially women, do not have obstructive coronary artery disease (CAD) yet have impaired prognosis. We investigated whether routine assessment of coronary microvascular dysfunction (CMD) is feasible and predicts adverse outcome in women with angina and no obstructive CAD. METHODS AND RESULTS: After screening 7253, we included 1853 women with angina and no obstructive CAD on angiogram who were free of previous CAD, heart failure, or valvular heart disease in the prospective iPOWER (Improving Diagnosis and Treatment of Women with Angina Pectoris and Microvascular Disease) study. CMD was assessed by Doppler echocardiography in the left anterior descending artery as coronary flow velocity reserve (CFVR). Patients were followed for a composite outcome of cardiovascular death, myocardial infarction (MI), heart failure, stroke, and coronary revascularization. CFVR was obtained in 1681 patients (91%) and the median CFVR was 2.33 (quartiles 1-3: 2.00-2.74). During a median follow-up of 4.5 years, 96 events occurred. In univariate Cox regression, CFVR was associated with the composite outcome {hazard ratio (HR) 1.07 [95% confidence interval (CI) 1.03-1.11] per 0.1 unit decrease in CFVR; P < 0.001}, primarily driven by an increased risk of MI and heart failure. Results remained significant in multivariate analysis [HR 1.05 (95% CI 1.01-1.09) per 0.1 unit decrease in CFVR; P = 0.01]. In exploratory analyses, CFVR was also associated with the risk of repeated hospital admission for angina and all-cause mortality. CONCLUSION: Assessment of CFVR by echocardiography is feasible and predictive of adverse outcome in women with angina and no obstructive CAD. Results support a more aggressive preventive management of these patients and underline the need for trials targeting CMD.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Schroder J, Michelsen MM, Mygind ND, et al. Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study. Eur Heart J. 2021. PMID: 33477168. doi:10.1093/eurheartj/ehaa944

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。